I am excited to identify new opportunities across the dynamic healthcare landscape and collaborate with an intellectually curious team."

As a Business Development Manager in the Healthcare vertical, Francesca executes top-of-funnel tasks – working with the deal team to find interesting businesses within the firm’s Identified Sector Opportunities (ISOs), building relationships with those businesses and attending industry conferences.

 

Before joining the THL team, Francesca worked at William Blair as an Investment Banking Analyst in the Healthcare group. In her free time, Francesca enjoys finding new trails to run in New England and cheering on the Cincinnati Bengals.

Verticals
Healthcare (HC)
Verticals
Healthcare (HC)

Related content

Why We Invested in Celerion: Advancing the Future of Clinical Pharmacology
Insights
Why We Invested in Celerion: Advancing the Future of Clinical Pharmacology 

Key Takeaways: In April 2026, THL announced a majority investment in Celerion, a global leader in clinical pharmacology and bioanalytical sciences that supports pharmaceutical and biotechnology companies in advancing new therapies through critical stages of clinical development. As drug development becomes increasingly complex — driven by novel therapeutic modalities, precision medicine, and evolving regulatory requirements — clinical

Healthcare (HC)

Want to learn more?